Innogen Pharma enters into billion dollar deal with Arcera Life Sciences for GLP-1 therapy

China-based Innogen Pharmaceuticals has entered into an exclusive licensing and commercialisation agreement with Arcera ...

November 20, 2026 | Friday | News
Pfizer inks $2.3 B CAR-T deal with China's Starna Therapeutics

Pfizer Inc. has entered into an exclusive licensing agreement with China-based Starna Therapeutics, a biotechnology comp...

November 19, 2026 | Thursday | News
Lonza licenses NeuroPortal™ blood-brain barrier technology to CMS for neurodegenerative therapies

    - Lonza and China Medical System Holdings Limited (CMS) announced  a global ex...

November 17, 2026 | Tuesday | News
Delonix Bioworks and A*STAR Infectious Diseases Labs partner to develop OMV vaccine candidates against Klebsiella pneumoniae

Delonix Bioworks, a China-based clinical-stage biotechnology startup pioneering next-generation outer membrane vesicle (...

November 17, 2026 | Tuesday | News
Hong Kong establishes first Calculus Bovis research centre for traditional medicines

The School of Chinese Medicine (SCM) at Hong Kong Baptist University (HKBU) and Poseidon Pharmaceutical Company Limited ...

November 16, 2026 | Monday | News
10x Genomics teams up with Fudan University and SPDx to study breast cancer

10x Genomics, Inc., the life science technology leader focused on accelerating science and advancing human health, has a...

November 11, 2026 | Wednesday | News
Fresenius and WuXi Biologics enter exclusive development agreement to expand biosimilars pipeline

Germany-based Fresenius SE & Co. KGaA has entered an exclusive development agreement with China's WuXi Biologics, a ...

November 13, 2026 | Friday | News
Laboratoires Pierre Fabre and XtalPi announce AI-driven collaboration focused on drug discovery

France-based Laboratoires Pierre Fabre and China's XtalPi have announced an agreement under which they will collaborate ...

November 9, 2026 | Monday | News
Boehringer Ingelheim and Sino Biopharma advance next-gen cancer therapies with $7 B deal

Boehringer Ingelheim, headquartered in Germany, and China-based Sino Biopharmaceutical (together with its subsidiaries, ...

November 6, 2026 | Friday | News
Zuellig Pharma strengthens clinical sourcing capabilities in China through strategic acquisition

Zuellig Pharma, a leading healthcare solutions company in Asia, has announced the strategic acquisition of a specialised...

November 4, 2026 | Wednesday | News
Japan's Shionogi transfers generic drug business to Zhejiang Gaozhi Pharma in China

Japan-based pharma firm Shionogi has announced that Shionogi China, a Shionogi group company in China, has entered into ...

November 3, 2026 | Tuesday | News
Jiahui launches International Cell Therapy Centre to expand global access to CAR-T treatment

Jiahui International Hospital has launched Jiahui International Cell Therapy Centre (JICC), building on landmark CAR-T c...

October 29, 2026 | Thursday | News
Gilead buys oral IL-23R inhibitor programme from China's PepStar for $1.27 B

US-based Gilead Sciences, Inc. has entered into a definitive agreement to acquire an oral IL-23R inhibitor programme, in...

October 28, 2026 | Wednesday | News
Natus opens Suzhou Facility for advancing medical diagnostics innovation in China

US-based Natus Medical Incorporated, the world's largest pure-play neurodiagnostic company, recently celebrated the gran...

October 27, 2026 | Tuesday | News
HighTide presents preclinical HTD1801 findings in polycystic kidney disease

HighTide Therapeutics, Inc., an innovative biopharmaceutical company specializing in the development of multifunctional,...

October 26, 2026 | Monday | News
Chinese National Medical Products Administration approves Galderma's injectable aesthetics Relfydess™

Galderma has announced that the Chinese National Medical Products Administration (NMPA) has approved Relf...

October 23, 2026 | Friday | News
ESTEVE CDMO expands presence in Asia with major investment and new manufacturing site in China

ESTEVE CDMO, Esteve Healthcare contract development and manufacturing organization, is strengthening its presence in Asi...

October 22, 2026 | Thursday | News
China's startup Metis TechBio strikes drug-delivery deal worth $1.1 B with Eli Lilly

METiS TechBio, the innovator in AI-powered drug delivery, has announced a strategic collaboration with US-based Eli Lill...

October 21, 2026 | Wednesday | News
China and India can strengthen APAC’s global MedTech role: APACMed’s Arjun Sarker

China and India are contributing different strengths to Asia Pacific’s medical technology industry, from manufactu...

October 19, 2026 | Monday | Opinion
China's Brii Biosciences unveils BRiSC™, an siRNA Therapeutics discovery platform

Brii Biosciences, a China-based biotechnology company developing therapies to improve patient health and choice across d...

October 16, 2026 | Friday | News
Roche inks $1.06 B deal with China's Rona Therapeutics for RNA-based metabolic therapies

Chinese startup Rona Therapeutics has granted Roche an exclusive worldwide license for Rona's investigational RNAi candi...

October 14, 2026 | Wednesday | News
Americhem opens new clean compounding facility in Suzhou, China

Americhem, a global leader in custom polymer solutions, recently celebrated the opening of its new clean compounding fac...

October 13, 2026 | Tuesday | News
Foresee Pharma announces China NMPA approval of CAMCEVI® 42 mg for treatment of advanced prostate cancer

Taiwan-based Foresee Pharmaceuticals has been notified by its licensing partner, Changchun GeneScience Pharmaceutical (G...

October 12, 2026 | Monday | News
Everest Medicines announces NMPA acceptance of LEROCHOL BLA for hypercholesterolemia

Everest Medicines announced on June 26, 2026, that China’s National Medical Products Administration (NMPA) accepte...

October 12, 2026 | Monday | News
China's XtalPi debuts Kodexia™ as world's first closed-loop siRNA platform

China's XtalPi Holdings, an AI and robotics-driven drug and materials discovery company, has debuted Kodexia™, the...

October 8, 2026 | Thursday | News